Clinical history of female-to-male transgender patients is needed to avoid misinterpretation of cervical Papanicolaou tests.

Neda A MoatamedAdriana Del BarcoSung-Eun YangYong YingSarah ZhangErika F Rodriguez

Published in: Cytopathology : official journal of the British Society for Clinical Cytology (2023)

Our findings indicate that clinical information regarding whether a subject is transgender and/or is receiving testosterone therapy is crucial to avoiding Pap test overcalls.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
healthcare
stem cells
replacement therapy
patient reported outcomes
mesenchymal stem cells
health information
patient reported
bone marrow